Around 22% of BCs are estimated to exhibit a BRCA1/2 alteration, whereas a functional deficit in the HR system overseen by BRCA1 has been identified in 69% of triple-negative breast cancers (TNBCs). Here, BRCA1 is linked to triple-negative breast carcinoma.